These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17785813)

  • 1. DAP10 deficiency breaks the immune tolerance against transplantable syngeneic melanoma.
    Hyka-Nouspikel N; Lucian L; Murphy E; McClanahan T; Phillips JH
    J Immunol; 2007 Sep; 179(6):3763-71. PubMed ID: 17785813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
    Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
    J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.
    Ramirez-Montagut T; Chow A; Hirschhorn-Cymerman D; Terwey TH; Kochman AA; Lu S; Miles RC; Sakaguchi S; Houghton AN; van den Brink MR
    J Immunol; 2006 Jun; 176(11):6434-42. PubMed ID: 16709800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
    Winter H; Hu HM; McClain K; Urba WJ; Fox BA
    J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice.
    Sfondrini L; Besusso D; Zoia MT; Rodolfo M; Invernizzi AM; Taniguchi M; Nakayama T; Colombo MP; Ménard S; Balsari A
    J Immunol; 2002 Jul; 169(1):151-8. PubMed ID: 12077240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
    J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity.
    Hyka-Nouspikel N; Phillips JH
    Immunol Rev; 2006 Dec; 214():106-17. PubMed ID: 17100879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
    J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
    Ribas A; Wargo JA; Comin-Anduix B; Sanetti S; Schumacher LY; McLean C; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS
    J Immunol; 2004 Apr; 172(8):4762-9. PubMed ID: 15067052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
    Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
    J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
    Smyth MJ; Taniguchi M; Street SE
    J Immunol; 2000 Sep; 165(5):2665-70. PubMed ID: 10946296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
    Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
    J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.
    Toura I; Kawano T; Akutsu Y; Nakayama T; Ochiai T; Taniguchi M
    J Immunol; 1999 Sep; 163(5):2387-91. PubMed ID: 10452972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.